The Cigna Group
CI
$271.63
-$9.64-3.43%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 10.34% | 9.28% | 11.20% | 14.57% | 28.62% |
| Total Other Revenue | 22.38% | 174.12% | -26.48% | -17.93% | -4.48% |
| Total Revenue | 10.39% | 9.50% | 11.00% | 14.40% | 28.44% |
| Cost of Revenue | 11.60% | 11.00% | 12.98% | 15.78% | 32.88% |
| Gross Profit | -0.70% | -3.42% | -5.45% | 3.48% | -1.69% |
| SG&A Expenses | -9.85% | -10.33% | -9.67% | 3.57% | 0.45% |
| Depreciation & Amortization | 9.20% | 0.00% | 0.48% | -0.24% | -5.99% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.31% | 9.69% | 11.48% | 14.84% | 30.03% |
| Operating Income | 12.64% | 5.16% | -0.28% | 4.01% | -4.26% |
| Income Before Tax | -9.56% | 92.53% | 1.61% | 1,986.08% | 968.62% |
| Income Tax Expenses | 14.80% | -12.26% | 8.06% | -17.87% | 151.47% |
| Earnings from Continuing Operations | -17.06% | 139.15% | 0.18% | 764.62% | 38.75% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 64.29% | -22.09% | -23.46% | -32.31% | -43.59% |
| Net Income | -13.34% | 152.77% | -1.03% | 577.62% | 38.39% |
| EBIT | 12.64% | 5.16% | -0.28% | 4.01% | -4.26% |
| EBITDA | 12.44% | 5.57% | -1.96% | 0.82% | -7.01% |
| EPS Basic | -8.84% | 164.70% | 4.53% | 605.10% | 46.75% |
| Normalized Basic EPS | 29.65% | 11.35% | 5.65% | 6.80% | -0.96% |
| EPS Diluted | -9.29% | 165.40% | 4.77% | 600.00% | 46.76% |
| Normalized Diluted EPS | 28.87% | 11.85% | 5.96% | 5.98% | -0.96% |
| Average Basic Shares Outstanding | -4.94% | -4.50% | -5.32% | -5.44% | -5.70% |
| Average Diluted Shares Outstanding | -4.36% | -4.93% | -5.60% | -4.72% | -5.70% |
| Dividend Per Share | 7.86% | 7.86% | 7.86% | 7.86% | 13.82% |
| Payout Ratio | 0.19% | -0.59% | 0.03% | 1.22% | -0.22% |